Evidence map›Paper›PMID 34155901›Full record

ArticleJournal of the American Heart Association2021

The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation.

Nicholas W Chavkin, Soichi Sano, Ying Wang, Kosei Oshima, Hayato Ogawa, Keita Horitani, Miho Sano, Susan MacLauchlan, Anders Nelson, Karishma Setia and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Disruption of theNature cardiovascular research · 2024
    Article
  7. Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis.American journal of physiology. Heart and circulatory physiology · 2024
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Nicholas W ChavkinCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Soichi SanoCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Ying WangCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Kosei OshimaMolecular Cardiology/Whitaker Cardiovascular Institute Boston University School of Medicine Boston MA.
Hayato OgawaCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Keita HoritaniCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Miho SanoCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Susan MacLauchlanMolecular Cardiology/Whitaker Cardiovascular Institute Boston University School of Medicine Boston MA.
Anders NelsonCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Karishma SetiaCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Tanvi VippaCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Yosuke WatanabeVascular Biology/Whitaker Cardiovascular Institute Boston University School of Medicine Boston MA.
Jeffrey J SaucermanCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Karen K HirschiCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Noyan GokceBoston University School of Medicine Boston MA.
Kenneth WalshCardiovascular Research Center School of Medicine University of Virginia Charlottesville VA.
Boston University · USUniversity of Virginia · USOsaka City University · JPYale University · US

Funding

BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
Multidisciplinary Training in Cardiovascular ResearchT32HL007224 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAMBURG, NAOMI MIRIAM, WAINFORD, RICHARD DAVID · 1985 to 2020
$12.3M
Wnt signaling control of vascular phenotype in obesityR01HL142650 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GOKCE, NOYAN, WALSH, KENNETH · 2019 to 2023
$3.1M
Somatic TET2 mutations in cardiac remodelingR01HL138014 · NHLBI · UNIVERSITY OF VIRGINIA · PI WALSH, KENNETH · 2017 to 2020
$2.6M
Endothelial Cell Cycle State and Cell FateR01HL146056 · NHLBI · UNIVERSITY OF VIRGINIA · PI HIRSCHI, KAREN KEMPER · 2019 to 2022
$2.1M
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicityR01HL152174 · NHLBI · UNIVERSITY OF VIRGINIA · PI WALSH, KENNETH · 2020 to 2024
$2.0M
Hematopoietic stem cell mutations and ischemic cardio-metabolic diseaseR01HL141256 · NHLBI · UNIVERSITY OF VIRGINIA · PI WALSH, KENNETH · 2019 to 2022
$1.9M
Systems Pharmacology Model for Spatial Control of Cardiac FibrosisR01HL137755 · NHLBI · UNIVERSITY OF VIRGINIA · PI HOLMES, JEFFREY W, SAUCERMAN, JEFFREY J. · 2017 to 2020
$1.9M
Integrated heart-liver-vascular systems for drug testing in human health and diseUH2EB017103 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2012 to 2013
$1.7M
NHLBI NIH HHS R01 HL137755NHLBI NIH HHS R01 HL138014NHLBI NIH HHS R01 HL141256NHLBI NIH HHS R01 HL142650NHLBI NIH HHS R01 HL146056NHLBI NIH HHS R01 HL152174NHLBI NIH HHS T32 HL007224NHLBI NIH HHS T32 HL007284NIBIB NIH HHS UH2 EB017103
6 · The paper itself

Abstract

Background A hallmark of heart failure is cardiac fibrosis, which results from the injury-induced differentiation response of resident fibroblasts to myofibroblasts that deposit extracellular matrix. During myofibroblast differentiation, fibroblasts progress through polarization stages of early proinflammation, intermediate proliferation, and late maturation, but the regulators of this progression are poorly understood. Planar cell polarity receptors, receptor tyrosine kinase-like orphan receptor 1 and 2 (Ror1/2), can function to promote cell differentiation and transformation. In this study, we investigated the role of the Ror1/2 in a model of heart failure with emphasis on myofibroblast differentiation. Methods and Results The role of Ror1/2 during cardiac myofibroblast differentiation was studied in cell culture models of primary murine cardiac fibroblast activation and in knockout mouse models that underwent transverse aortic constriction surgery to induce cardiac injury by pressure overload. Expression of Ror1 and Ror2 were robustly and exclusively induced in fibroblasts in hearts after transverse aortic constriction surgery, and both were rapidly upregulated after early activation of primary murine cardiac fibroblasts in culture. Cultured fibroblasts isolated from Ror1/2 knockout mice displayed a proinflammatory phenotype indicative of impaired myofibroblast differentiation. Although the combined ablation of Ror1/2 in mice did not result in a detectable baseline phenotype, transverse aortic constriction surgery led to the death of all mice by day 6 that was associated with myocardial hyperinflammation and vascular leakage. Conclusions Together, these results show that Ror1/2 are essential for the progression of myofibroblast differentiation and for the adaptive remodeling of the heart in response to pressure overload.

Indexed as

Ventricular RemodelingAnimalsCell DifferentiationExtracellular MatrixFemaleFibroblastsFibrosisHeart FailureMaleMiceMice, Inbred C57BLMice, KnockoutMyocardiumMyofibroblastsReceptor Tyrosine Kinase-like Orphan ReceptorsUp-RegulationReceptor Tyrosine Kinase-like Orphan ReceptorsRor1 protein, mouseRor2 protein, mousefibroblastsfibrosisheart failureinflammationmyocardial inflammation

Identifiers

PMID34155901
PMCPMC8403294
OpenAlexW3177094136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.